
Joris De Wit is a co-founder of Augustine Therapeutics, a Belgian biotech developing treatments for neuromuscular and neurodegenerative diseases that raised EUR 77.7M in a Series A round in H1 2025.
De Wit co-founded Augustine Therapeutics alongside Ludo Van Den Bosch and Bart De Strooper, researchers with strong academic credentials in neuroscience. The EUR 77.7M Series A closed in H1 2025 is one of the larger biotech rounds in recent Belgian history, with PMV among the backers.
From public career histories · 2 entries